Jinzhongzi Liquor Narrows Nine-Month Loss to 98.55 Million Yuan

The headline loss narrowing is less telling than the revenue collapse: a 50% top-line decline, still down over 40% even after stripping out the Jintaiyang Pharmaceutical consolidation change, points to genuine demand weakness rather than accounting noise. That distinction matters for anyone tracking the broader baijiu sector, where volume softness at smaller regional names can signal pressure that larger players may later face. Whether the ex-pharma revenue decline stabilizes once the consolidation effect annualizes is the open question.